Replies to post #40271 on Easton Pharmaceuticals, Inc. (EAPH)

[mckinley1]

For sure! $EAPH$ will be over .10 even if the Pharmaceutical JV Partnership is not with BAYER. The revenues generated from this under serviced Region of the World in Women's Health Products and Cancer Drugs is mind-blowing. The Exclusive Mexican Ministry of Health Approval for the $EAPH$ Women's Health Products opens the door to the many Health Care Products and Medical Equipment $EAPH$ has in the pipeline. Great opportunity for $EAPH$ and the shareholders. GLTY!